There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Janux Therapeutics Inc (JANX – Research Report), Madrigal Pharmaceuticals (MDGL – Research Report) and Eledon Pharmaceuticals (ELDN – Research Report) with bullish sentiments.
Janux Therapeutics Inc (JANX)
H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating on Janux Therapeutics Inc today and set a price target of $35.00. The company’s shares closed last Friday at $6.04, close to its 52-week low of $5.65.
According to TipRanks.com, Ramakanth has 0 stars on 0-5 stars ranking scale with an average return of
Currently, the analyst consensus on Janux Therapeutics Inc is a Moderate Buy with an average price target of $35.00, implying a 498.3% upside from current levels. In a report issued on November 7, TD Cowen also maintained a Buy rating on the stock.
See today’s best-performing stocks on TipRanks >>
Madrigal Pharmaceuticals (MDGL)
H.C. Wainwright analyst Ed Arce maintained a Buy rating on Madrigal Pharmaceuticals today and set a price target of $275.00. The company’s shares closed last Friday at $138.84.
According to TipRanks.com, Arce is a 3-star analyst with an average return of
Madrigal Pharmaceuticals has an analyst consensus of Strong Buy, with a price target consensus of $308.43, representing a 123.3% upside. In a report issued on November 6, TD Cowen also maintained a Buy rating on the stock with a $396.00 price target.
Eledon Pharmaceuticals (ELDN)
In a report released today, Vernon Bernardino from H.C. Wainwright reiterated a Buy rating on Eledon Pharmaceuticals, with a price target of $13.00. The company’s shares closed last Friday at $1.16, close to its 52-week low of $1.07.
According to TipRanks.com, Bernardino is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Eledon Pharmaceuticals with a $15.60 average price target, representing a 1233.3% upside. In a report issued on November 3, LifeSci Capital also maintained a Buy rating on the stock with a $9.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on JANX:
